Does humira cause hair loss?

Does Humira cause hair loss?

Humira can trigger hair loss in some people, though it is uncommon. The drug’s label lists alopecia as a possible side effect, and post-marketing reports show cases of hair thinning or patchy loss. Most patients do not experience this reaction, but the risk rises with longer use and higher doses.

Why do some patients lose hair while taking Humira?

Humira blocks TNF-alpha, a protein that helps regulate immune activity. When TNF is suppressed, the immune system can shift and occasionally attack hair follicles, producing a reaction called alopecia areata. The same mechanism also explains why some users develop other autoimmune skin problems such as psoriasis or eczema.

How long does it usually take for hair loss to appear?

Reports show onset anywhere from a few weeks to more than a year after starting treatment. In most documented cases the loss begins within the first six months. Hair may shed gradually or in distinct patches, and regrowth can begin once the drug is stopped or the dose lowered.

What happens if you keep taking Humira after hair loss starts?

Continuing therapy can worsen the hair loss in sensitive individuals. Dermatologists sometimes add topical steroids or minoxidil while the patient remains on Humira, but results vary. If the loss becomes distressing, switching to a different biologic or tapering off Humira often reverses the problem within several months.

Can biosimilars cause the same hair-loss problem?

Yes. Adalimumab biosimilars carry the same TNF-blocking action and the same alopecia warning. No large head-to-head studies prove one version safer than another for hair, so the choice between reference Humira and a biosimilar is usually driven by cost and insurance coverage rather than hair-loss risk.

When does the Humira patent expire and what does that mean for patients worried about side effects?

The main U.S. patent for Humira expired in 2023, allowing multiple biosimilars to launch. The increased competition has lowered prices, but it has not changed the drug’s safety profile. Patients concerned about hair loss can discuss switching to a lower-cost biosimilar or to a different class of therapy with their prescriber.

What other side effects are patients most often asking about?

Common questions focus on infection risk, injection-site reactions, and possible links to cancer or nervous-system disorders. Hair loss ranks lower in frequency but higher in visibility, which is why dermatology referrals are common once thinning is noticed.

DrugPatentWatch.com